780 related articles for article (PubMed ID: 28912152)
1. Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case-Control Study in Northern and Eastern China and Implications for Chemoprevention.
Wang F; Liu L; Cui S; Tian F; Fan Z; Geng C; Cao X; Yang Z; Wang X; Liang H; Wang S; Jiang H; Duan X; Wang H; Li G; Wang Q; Zhang J; Jin F; Tang J; Li L; Zhu S; Zuo W; Ma Z; Zhou F; Yu L; Xiang Y; Li L; Shen S; Yu Z
Oncologist; 2017 Dec; 22(12):1431-1443. PubMed ID: 28912152
[TBL] [Abstract][Full Text] [Related]
2. Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the shanghai breast cancer study.
Bao PP; Shu XO; Gao YT; Zheng Y; Cai H; Deming SL; Ruan ZX; Su Y; Gu K; Lu W; Zheng W
Am J Epidemiol; 2011 Sep; 174(6):661-71. PubMed ID: 21768404
[TBL] [Abstract][Full Text] [Related]
3. Body mass index at age 18 years and recent body mass index in relation to risk of breast cancer overall and ER/PR/HER2-defined subtypes in white women and African-American women: a pooled analysis.
Ma H; Ursin G; Xu X; Lee E; Togawa K; Malone KE; Marchbanks PA; McDonald JA; Simon MS; Folger SG; Lu Y; Sullivan-Halley J; Deapen DM; Press MF; Bernstein L
Breast Cancer Res; 2018 Jan; 20(1):5. PubMed ID: 29357906
[TBL] [Abstract][Full Text] [Related]
4. Hip circumference is associated with the risk of premenopausal ER-/PR- breast cancer.
Fagherazzi G; Chabbert-Buffet N; Fabre A; Guillas G; Boutron-Ruault MC; Mesrine S; Clavel-Chapelon F
Int J Obes (Lond); 2012 Mar; 36(3):431-9. PubMed ID: 21427693
[TBL] [Abstract][Full Text] [Related]
5. The diverse distribution of risk factors between breast cancer subtypes of ER, PR and HER2: a 10-year retrospective multi-center study in China.
Song Q; Huang R; Li J; Fan J; Zheng S; Zhang B; Yang H; Tang Z; He J; Xie X; Li H; Li J; Qiao Y
PLoS One; 2013; 8(8):e72175. PubMed ID: 23977244
[TBL] [Abstract][Full Text] [Related]
6. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.
Enger SM; Ross RK; Paganini-Hill A; Carpenter CL; Bernstein L
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):681-7. PubMed ID: 10919738
[TBL] [Abstract][Full Text] [Related]
7. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.
Ritte R; Lukanova A; Berrino F; Dossus L; Tjønneland A; Olsen A; Overvad TF; Overvad K; Clavel-Chapelon F; Fournier A; Fagherazzi G; Rohrmann S; Teucher B; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Panico S; Tumino R; Vineis P; Quirós JR; Buckland G; Sánchez MJ; Amiano P; Chirlaque MD; Ardanaz E; Sund M; Lenner P; Bueno-de-Mesquita B; van Gils CH; Peeters PH; Krum-Hansen S; Gram IT; Lund E; Khaw KT; Wareham N; Allen NE; Key TJ; Romieu I; Rinaldi S; Siddiq A; Cox D; Riboli E; Kaaks R
Breast Cancer Res; 2012 May; 14(3):R76. PubMed ID: 22583394
[TBL] [Abstract][Full Text] [Related]
8. Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype.
Shieh Y; Scott CG; Jensen MR; Norman AD; Bertrand KA; Pankratz VS; Brandt KR; Visscher DW; Shepherd JA; Tamimi RM; Vachon CM; Kerlikowske K
Breast Cancer Res; 2019 Apr; 21(1):48. PubMed ID: 30944014
[TBL] [Abstract][Full Text] [Related]
9. Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there?
Potter JD; Cerhan JR; Sellers TA; McGovern PG; Drinkard C; Kushi LR; Folsom AR
Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):319-26. PubMed ID: 7655325
[TBL] [Abstract][Full Text] [Related]
10. Relationship between body mass index, waist circumference and waist to hip ratio and the steroid hormone receptor status in breast carcinoma of pre- and postmenopausal women.
Pinheiro RL; Sarian LO; Pinto-Neto AM; Morais S; Costa-Paiva L
Breast; 2009 Feb; 18(1):8-12. PubMed ID: 19041243
[TBL] [Abstract][Full Text] [Related]
11. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status--the Japan public health center-based prospective study.
Suzuki R; Iwasaki M; Inoue M; Sasazuki S; Sawada N; Yamaji T; Shimazu T; Tsugane S;
Int J Cancer; 2011 Sep; 129(5):1214-24. PubMed ID: 21064092
[TBL] [Abstract][Full Text] [Related]
12. Association of white blood cell count with breast cancer burden varies according to menopausal status, body mass index, and hormone receptor status: a case-control study.
Park B; Lee HS; Lee JW; Park S
Sci Rep; 2019 Apr; 9(1):5762. PubMed ID: 30962496
[TBL] [Abstract][Full Text] [Related]
13. Association of physical activity with hormone receptor status: the Shanghai Breast Cancer Study.
Adams SA; Matthews CE; Hebert JR; Moore CG; Cunningham JE; Shu XO; Fulton J; Gao Y; Zheng W
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1170-8. PubMed ID: 16775177
[TBL] [Abstract][Full Text] [Related]
14. A body shape index (ABSI) is associated inversely with post-menopausal progesterone-receptor-negative breast cancer risk in a large European cohort.
Christakoudi S; Tsilidis KK; Dossus L; Rinaldi S; Weiderpass E; Antoniussen CS; Dahm CC; Tjønneland A; Mellemkjær L; Katzke V; Kaaks R; Schulze MB; Masala G; Grioni S; Panico S; Tumino R; Sacerdote C; May AM; Monninkhof EM; Quirós JR; Bonet C; Sánchez MJ; Amiano P; Chirlaque MD; Guevara M; Rosendahl AH; Stocks T; Perez-Cornago A; Tin Tin S; Heath AK; Aglago EK; Peruchet-Noray L; Freisling H; Riboli E
BMC Cancer; 2023 Jun; 23(1):562. PubMed ID: 37337133
[TBL] [Abstract][Full Text] [Related]
15. Obesity, body fat distribution, and risk of breast cancer subtypes in African American women participating in the AMBER Consortium.
Bandera EV; Chandran U; Hong CC; Troester MA; Bethea TN; Adams-Campbell LL; Haiman CA; Park SY; Olshan AF; Ambrosone CB; Palmer JR; Rosenberg L
Breast Cancer Res Treat; 2015 Apr; 150(3):655-66. PubMed ID: 25809092
[TBL] [Abstract][Full Text] [Related]
16. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
[TBL] [Abstract][Full Text] [Related]
17. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis.
Suzuki R; Orsini N; Saji S; Key TJ; Wolk A
Int J Cancer; 2009 Feb; 124(3):698-712. PubMed ID: 18988226
[TBL] [Abstract][Full Text] [Related]
18. Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis.
Vrieling A; Buck K; Kaaks R; Chang-Claude J
Breast Cancer Res Treat; 2010 Oct; 123(3):641-9. PubMed ID: 20711809
[TBL] [Abstract][Full Text] [Related]
19. High fasting blood glucose and obesity significantly and independently increase risk of breast cancer death in hormone receptor-positive disease.
Minicozzi P; Berrino F; Sebastiani F; Falcini F; Vattiato R; Cioccoloni F; Calagreti G; Fusco M; Vitale MF; Tumino R; Sigona A; Budroni M; Cesaraccio R; Candela G; Scuderi T; Zarcone M; Campisi I; Sant M
Eur J Cancer; 2013 Dec; 49(18):3881-8. PubMed ID: 24011933
[TBL] [Abstract][Full Text] [Related]
20. Central obesity increases risk of breast cancer irrespective of menopausal and hormonal receptor status in women of South Asian Ethnicity.
Nagrani R; Mhatre S; Rajaraman P; Soerjomataram I; Boffetta P; Gupta S; Parmar V; Badwe R; Dikshit R
Eur J Cancer; 2016 Oct; 66():153-61. PubMed ID: 27573429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
